PULMONARY ARTERIAL HYPERTENSION
Clinical trials for PULMONARY ARTERIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could ease strain on lungs for PAH patients
Disease control Not yet recruitingThis study tests an oral drug called NS-863 in 135 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes the heart work harder. Participants will take either NS-863 or a placebo daily for 24 weeks to see if the drug improves b…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
New daily inhaler could help PAH patients walk farther
Disease control Not yet recruitingThis study tests a once-daily inhaled powder (TPIP) to see if it helps people with pulmonary arterial hypertension (PAH) walk farther. About 344 adults with PAH will receive either TPIP or a placebo for 24 weeks. The main goal is to measure changes in a 6-minute walk test.
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
Could a new drug ease the strain on hearts of PAH patients?
Disease control Not yet recruitingThis early-stage study tests a drug called 2-HOBA in 12 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure damages the lungs and heart. The goal is to see if the drug can improve heart function and reduce signs of disease. Participants must b…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Rare lung disease treatment switch under review
Knowledge-focused Not yet recruitingThis study examines what happens when people with pulmonary arterial hypertension (PAH) switch from one medication to another as part of their triple therapy. Researchers will look at medical records from 15 adults to see if the switch improves walking distance, symptoms, and blo…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Sponsor: Caio Júlio César dos Santos Fernandes • Aim: Knowledge-focused
Last updated May 26, 2026 05:04 UTC
-
Sleep trouble and heart strain: new study tracks hidden risks in lung disease
Knowledge-focused Not yet recruitingThis study follows 60 adults with pulmonary hypertension to see how sleep-related breathing problems and heart rate changes evolve over two years. Participants will have overnight sleep tests at the start, 12 months, and 24 months. The goal is to find better ways to predict and m…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated May 26, 2026 05:03 UTC